(PJP) Invesco Dynamic - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46137V6627 • Health
PJP: Drugs, Pharmaceuticals, Medications, Vaccines, Biologics, Therapies
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified. ‣ Company URL: http://www.invesco.com/us ‣ Domicile: United States
Additional Sources for PJP ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PJP ETF Overview
| Market Cap in USD | 268m |
| Category | Health |
| TER | 0.57% |
| IPO / Inception | 2005-06-23 |
PJP ETF Ratings
| Growth 5y | 51.5% |
| Fundamental | - |
| Dividend | 52.6% |
| Rel. Strength Industry | -63 |
| Analysts | - |
| Fair Price Momentum | 76.98 USD |
| Fair Price DCF | - |
PJP Dividends
| Dividend Yield 12m | 0.96% |
| Yield on Cost 5y | 1.32% |
| Annual Growth 5y | 8.26% |
| Payout Consistency | 82.8% |
PJP Growth Ratios
| Growth Correlation 3m | -78.9% |
| Growth Correlation 12m | 79% |
| Growth Correlation 5y | 63.9% |
| CAGR 5y | 6.48% |
| CAGR/Mean DD 5y | 1.14 |
| Sharpe Ratio 12m | 0.44 |
| Alpha | -9.68 |
| Beta | 0.67 |
| Volatility | 15.74% |
| Current Volume | 4k |
| Average Volume 20d | 6.6k |
What is the price of PJP stocks?
As of January 23, 2025, the stock is trading at USD 83.54 with a total of 4,000 shares traded.
Over the past week, the price has changed by +1.65%, over one month by +0.45%, over three months by -4.53% and over the past year by +10.02%.
As of January 23, 2025, the stock is trading at USD 83.54 with a total of 4,000 shares traded.
Over the past week, the price has changed by +1.65%, over one month by +0.45%, over three months by -4.53% and over the past year by +10.02%.
Is Invesco Dynamic a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Invesco Dynamic (NYSE ARCA:PJP) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.47 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PJP as of January 2025 is 76.98. This means that PJP is currently overvalued and has a potential downside of -7.85%.
Partly, yes. Based on ValueRay Analyses, Invesco Dynamic (NYSE ARCA:PJP) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.47 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PJP as of January 2025 is 76.98. This means that PJP is currently overvalued and has a potential downside of -7.85%.
Is PJP a buy, sell or hold?
Invesco Dynamic has no consensus analysts rating.
Invesco Dynamic has no consensus analysts rating.
What are the forecast for PJP stock price target?
According to ValueRays Forecast Model, PJP Invesco Dynamic will be worth about 84.7 in January 2026. The stock is currently trading at 83.54. This means that the stock has a potential upside of +1.36%.
According to ValueRays Forecast Model, PJP Invesco Dynamic will be worth about 84.7 in January 2026. The stock is currently trading at 83.54. This means that the stock has a potential upside of +1.36%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 84.7 | 1.4% |